Categories
Lupin Limited — Updates, 13-05-2026: Press Release
13-05-2026 · 06:26 pm
Lupin secured U.S. FDA approval for Famotidine Injection, USP. This drug, with estimated annual U.S. sales of USD 8.7 million, offers a new revenue opportunity and will be manufactured at its Nagpur facility.
No comments yet. Be the first to comment!